Literature DB >> 8287625

Silent solitary right parietal chondroma resulting in secondary mania.

V H Salazar-Calderon Perriggo1, K J Oommen, R E Sobonya.   

Abstract

We are reporting a case of manic depressive illness in a patient with a falxial chondroma in the right parietal region. Neurological symptoms were absent except for right hemicranial headache and examination was normal, prior to the presentation with mania. The mania responded to psychotropics. Subsequent evaluation with a head CT scan using contrast enhancement showed a 2.5 x 2 cm high density mass which on craniotomy and biopsy was noted to be a chondroma. For two years following removal, the patient remained euthymic without medication. To our knowledge, this is the fourth reported case of a chondroma in the parietal region and the first case of secondary mania associated with such a tumor.

Entities:  

Mesh:

Year:  1993        PMID: 8287625

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  3 in total

1.  Intracranial dural chondroma in a child-conventional and advanced neuroimaging characteristics and differential diagnosis.

Authors:  Shai Shrot; Alan R Cohen; Fausto J Rodriguez; Frank Berkowitz; Bruno P Soares; Thierry Agm Huisman
Journal:  Neuroradiol J       Date:  2017-06-20

2.  Giant Dural Supratentorial Chondroma Generating the Question of How Large Can a Tumor Become Without Revealing Itself.

Authors:  Alexandros Doukas; Annamarie Tallo; Richard Parvin; Volkmar Hans; Pooya Daemi; Azad Cheko; Martin Scholz; Athanasios K Petridis
Journal:  Clin Pract       Date:  2015-12-29

Review 3.  Right-sided brain lesions predominate among patients with lesional mania: evidence from a systematic review and pooled lesion analysis.

Authors:  J Bernardo Barahona-Corrêa; Gonçalo Cotovio; Rui M Costa; Ricardo Ribeiro; Ana Velosa; Vera Cruz E Silva; Christoph Sperber; Hans-Otto Karnath; Suhan Senova; Albino J Oliveira-Maia
Journal:  Transl Psychiatry       Date:  2020-05-12       Impact factor: 6.222

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.